Additional file 5: Figure S4. of EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance
- Florian Sevelda (541508)
- Lisa Mayr (3487286)
- Bernd Kubista (3487283)
- Daniela Lötsch (3487295)
- Sushilla Schoonhoven (3487292)
- Reinhard Windhager (310422)
- Christine Pirker (224780)
- Michael Micksche (2377774)
- Walter Berger (194987)
Publication date
November 2015
DOIAbstract
Impact of EGFR inhibition by gefitinib on cell cycle distribution. The indicated osteosarcoma cell lines were treated with gefitinib (1 μM, 5 μM and 10 μM) for 24 h in 1 % FCS containing culture medium and opposed to untreated cells at 10 % FCS (control). Cell cycle distribution was analysed by PI staining followed by FACS analysis. (PDF 56 kb
Add to ORKG